Laumas Sandeep

Director at Unicycive Therapeutics, Inc. · on record since May 18, 2026
Director at BioXcel Therapeutics, Inc. · on record since Mar 13, 2018
Director at Monster Digital, Inc. · on record since Feb 8, 2018
CEO, Executive Chairman at Monster Digital, Inc. · on record since May 23, 2019
Director at NEW YORK MORTGAGE TRUST INC · on record since May 4, 2020
CFO and CBO at TRANS-INDIA ACQUISITION CORP · on record since Mar 22, 2021
10% owner at TEXXON INC · on record since Jan 11, 2022

Insider trading activity of Laumas Sandeep

Transactions on record: 50; since Mar 13, 2018

Open-market buys: 16; $38.9K

Open-market sells: 2; $701.7K

Companies traded: 5; last filing Jun 15, 2026

Figures computed from official regulatory filings — methodology.

Companies where Laumas Sandeep has traded

Unicycive Therapeutics, Inc.6 tx · Jun 15, 2026
BioXcel Therapeutics, Inc.8 tx · Jan 12, 2026
TRANS-INDIA ACQUISITION CORP13 tx · $1.1M · Sep 12, 2025
NEW YORK MORTGAGE TRUST INC6 tx · Jul 8, 2020
Monster Digital, Inc.17 tx · $38.9K · Aug 27, 2019

Track record of Laumas Sandeep

Statistical track record

Free

Open-market buys: 18

Last buy: May 4, 2020

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Laumas Sandeep

Co-insiders of Laumas Sandeep

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Unicycive Therapeutics, Inc.	Jun 15, 2026	AwardD	42,100	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Jun 15, 2026	AwardD	84,200	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	May 18, 2026	AwardD	42,100	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	May 18, 2026	AwardD	84,200	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jan 12, 2026	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Exercise	17,000	11.60 USD	$197.2K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Sell	-12,461	23.88 USD	$297.6K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	ExerciseD	-13,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Sell	-17,539	23.04 USD	$404.1K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Exercise	13,000	12.68 USD	$164.8K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	ExerciseD	-17,000	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Jul 30, 2025	AwardD	21,200	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Apr 28, 2025	AwardD	44,851	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 23, 2024	AwardD	45,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 11, 2024	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Feb 13, 2024	AwardD	80,000	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Sep 7, 2023	AwardD	189,236	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 28, 2023	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Jan 20, 2023	AwardD	234,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Jan 20, 2023	AwardD	415,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	May 23, 2022	AwardD	17,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 15, 2021	AwardD	14,500	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	May 13, 2021	AwardD	200,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Mar 22, 2021	AwardD	240,000	0.00 USD	$0	SEC
NEW YORK MORTGAGE TRUST INC	Jul 8, 2020	AwardD	150,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Unicycive Therapeutics, Inc.	Jun 15, 2026	AwardD	42,100	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Jun 15, 2026	AwardD	84,200	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	May 18, 2026	AwardD	42,100	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	May 18, 2026	AwardD	84,200	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jan 12, 2026	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Exercise	17,000	11.60 USD	$197.2K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Sell	-12,461	23.88 USD	$297.6K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	ExerciseD	-13,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Sell	-17,539	23.04 USD	$404.1K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	Exercise	13,000	12.68 USD	$164.8K	SEC
TRANS-INDIA ACQUISITION CORP	Sep 12, 2025	ExerciseD	-17,000	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Jul 30, 2025	AwardD	21,200	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Apr 28, 2025	AwardD	44,851	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Sep 23, 2024	AwardD	45,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 11, 2024	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Feb 13, 2024	AwardD	80,000	0.00 USD	$0	SEC
Unicycive Therapeutics, Inc.	Sep 7, 2023	AwardD	189,236	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 28, 2023	AwardD	17,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Jan 20, 2023	AwardD	234,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Jan 20, 2023	AwardD	415,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	May 23, 2022	AwardD	17,000	0.00 USD	$0	SEC
BioXcel Therapeutics, Inc.	Jun 15, 2021	AwardD	14,500	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	May 13, 2021	AwardD	200,000	0.00 USD	$0	SEC
TRANS-INDIA ACQUISITION CORP	Mar 22, 2021	AwardD	240,000	0.00 USD	$0	SEC
NEW YORK MORTGAGE TRUST INC	Jul 8, 2020	AwardD	150,000	0.00 USD	$0	SEC